ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Icaritin ameliorates MPTP-induced Parkinson's disease model by targeting the NLRP3 inflammasome pathway.

Chengnian Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.